Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies

Systemic lupus erythematosus (SLE) and bullous pemphigoid (BP) are chronic autoimmune diseases in which B cells play an important pathogenic role in the different stages of the disease. B cell-targeted therapies have been suggested as a new rational approach for treating SLE. Rituximab (RTX), an ant...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Med (Lausanne)
Asıl Yazarlar: Petricca, Luca, Gigante, Maria Rita, Paglionico, Annamaria, Costanzi, Stefano, Vischini, Gisella, Di Mario, Clara, Varriano, Valentina, Tanti, Giacomo, Tolusso, Barbara, Alivernini, Stefano, Grandaliano, Giuseppe, Ferraccioli, Gianfranco, Gremese, Elisa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657367/
https://ncbi.nlm.nih.gov/pubmed/33195302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.553075
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller